ScoreWhy is Recursion Pharmaceuticals, Inc. ?
1
The company has declared negative results for the last 2 consecutive quarters
- NET PROFIT(HY) At USD -374.38 MM has Grown at -98.18%
- INTEREST(HY) At USD 0.99 MM has Grown at 138.65%
- OPERATING CASH FLOW(Y) Lowest at USD -383.03 MM
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -27.17%, its profits have fallen by -62.3%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -27.17% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Recursion Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Recursion Pharmaceuticals, Inc.
-30.61%
-0.51
95.82%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-64.74%
EBIT Growth (5y)
-222.25%
EBIT to Interest (avg)
-213.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.09
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
88.01%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.39
EV to EBIT
-3.07
EV to EBITDA
-3.36
EV to Capital Employed
3.78
EV to Sales
29.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-122.84%
ROE (Latest)
-61.54%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -374.38 MM
NET SALES(Q)
At USD 19.22 MM has Grown at 28.6%
-23What is not working for the Company
NET PROFIT(HY)
At USD -374.38 MM has Grown at -98.18%
INTEREST(HY)
At USD 0.99 MM has Grown at 138.65%
OPERATING CASH FLOW(Y)
Lowest at USD -383.03 MM
ROCE(HY)
Lowest at -86.34%
RAW MATERIAL COST(Y)
Grown by 958.35% (YoY
PRE-TAX PROFIT(Q)
At USD -171.9 MM has Fallen at -19.52%
Here's what is working for Recursion Pharmaceuticals, Inc.
Net Profit
Higher at USD -374.38 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 19.22 MM has Grown at 28.6%
over average net sales of the previous four periods of USD 14.95 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Depreciation
Highest at USD 23.85 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Recursion Pharmaceuticals, Inc.
Net Profit
At USD -374.38 MM has Grown at -98.18%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 0.99 MM has Grown at 138.65%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD -383.03 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD -171.9 MM has Fallen at -19.52%
over average net sales of the previous four periods of USD -143.82 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Raw Material Cost
Grown by 958.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
